Effects of Scaling and Root Planing With and Without Er:YAG Laser in Chronic Periodontitis Patients
NCT ID: NCT03003689
Last Updated: 2018-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
56 participants
INTERVENTIONAL
2017-04-20
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
While this method removes some of the bacteria that leads to periodontitis, microorganisms are not completely eliminated through SRP. Studies have shown that after 3 months, the bacteria initially present prior to scaling and root planing had recolonized. In order to prevent recurrence of periodontitis, it is recommended that oral bacteria be kept at low levels.
When used at the proper wave length, dental lasers have been shown to effectively removes calculus, without damaging surrounding tissue. The Er:YAG laser has been FDA-approved for the use of scaling and root planing in Dentistry. While studies on the Er:YAG laser have shown that it is effective in removing calculus and preserving the tooth root structure, there is no consensus of the level of calculus removal. The Er:YAG laser may also be more effective in removing microbial bacteria than SRP with hand instruments and ultrasonic scaler.
The purpose of this study is to evaluate the effectiveness of the Er:YAG laser, as an adjunct to scaling and root planing, in removing microbial bacteria. Participants with chronic periodontitis will be randomized to have one quadrant undergo scaling and root planing using hand instruments and ultrasonic scaler alone, while a second quadrant will receive the same treatment, with the addition of the Er:YAG laser. Outcomes studies will be traditional periodontal clinical parameters at 6 weeks and 3 months after treatment. Microbial cultures will be performed at baseline and 3 months to compare survival and re-population by periodontal microorganisms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Periodontitis With Er:YAG Laser
NCT03628872
Er:YAG Laser and Air Polishing Application in Periodontal Treatment
NCT06574802
Er:YAG Laser Treatment of Moderate Chronic Periodontitis
NCT05217823
Treatment of Periodontitis Using Er:YAG Laser vs. Conventional Treatment Modalities
NCT00669253
Study to Compare Laser Assisted New Attachment Procedure (LANAP) to Traditional Treatments of Chronic Periodontitis
NCT01282229
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary aim: The secondary aim of this study is to evaluate the efficacy of Er:YAG laser as an adjunct to mechanical scaling and root planing periodontal therapy by comparing gingival bleeding index and plaque index.
Tertiary aim: The tertiary aim of this study is to compare the microbial outcomes of mechanical periodontal therapy alone vs. mechanical therapy combined followed with Er:YAG laser therapy at the same time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scaling and Root Planing
Hand instruments + ultrasonic scaler
PD, CAL, plaque index and gingival bleeding index will be measured at baseline, 6 weeks and 3 months. Microbial load will be measured at baseline and 3 months.
Scaling and Root Planing
Standard of care scaling and root planing using hand instruments and ultrasonic scaler
Scaling and Root Planing + Er:YAG Laser
Er:YAG Laser, hand instruments + ultrasonic scaler
PD, CAL, plaque index and gingival bleeding index will be measured at baseline, 6 weeks and 3 months. Microbial load will be measured at baseline and 3 months.
Scaling and Root Planing
Standard of care scaling and root planing using hand instruments and ultrasonic scaler
Er:YAG Laser
Er:YAG laser as an adjunct therapy to standard of care scaling and root planing using hand instruments and ultrasonic
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Scaling and Root Planing
Standard of care scaling and root planing using hand instruments and ultrasonic scaler
Er:YAG Laser
Er:YAG laser as an adjunct therapy to standard of care scaling and root planing using hand instruments and ultrasonic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recent (within the past 30 days) diagnosis of moderate to severe chronic periodontitis in at least two quadrants according to the Armitage Classification
* Have had full mouth and vertical bite-wing series of diagnostic radiographs exposed at TUSDM within 6 months preceding entry of the study as a standard of care
* Have a treatment plan made by the original provider and certified by the PI based on the working diagnosis, presenting etiology, and the predicted therapeutic outcomes of the case (prognosis).
* Each of the two selected quadrants should have at least 5 teeth including the canine, first premolar and second premolar in contact with at least one tooth that has ≥ 5 mms and ≤ 9 mms probing depths with bleeding on probing.
Exclusion Criteria
* Participants with significant chronic oral soft tissue pathology (lichen planus, Benign Mucous Membrane Pemphigoid, Steven Johnson's Syndrome, Sjogren's Syndrome, etc.) which might affect host response to the presence of bacteria.
* Participants with fixed appliances or partial dentures, to standardize the effect of the treatment since they are plaque retentive.
* Participants who smoke tobacco
* Participants who require prophylactic antibiotics prior to dental treatment
* Participants who have taken systemic antibiotic medications within the previous 6 months
* Participants with uncontrolled systemic conditions or disease such as diabetes and immunological disorders
* Participants with known drug allergies or known adverse effects following the use of oral hygiene products.
* Participants who are pregnant or lactating
* Teeth with grade III mobility or teeth with hopeless prognosis indicated for extraction
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University School of Dental Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Hawley, DDS, MS, PhD
Role: PRINCIPAL_INVESTIGATOR
TUSDM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tufts University School of Dental Medicine
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12321
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.